T-cell receptor diversity prevents T-cell lymphoma development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

T-cell receptor diversity prevents T-cell lymphoma development

Published:2012-05-30 Issue:12 Volume:26 Page:2499-2507
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Newrzela S,Al-Ghaili N,Heinrich T,Petkova M,Hartmann S,Rengstl B,Kumar A,Jäck H-M,Gerdes S,Roeder I,Hansmann M-L,von Laer D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012142.pdf

Reference37 articles.

1. Dunleavy K, Piekarz RL, Zain J, Janik JE, Wilson WH, O’Connor OA et al. New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies. Clin Cancer Res 2010; 16: 5608–5617.

2. Min B, Paul WE . Endogenous proliferation: burst-like CD4 T cell proliferation in lymphopenic settings. Semin Immunol 2005; 17: 201–207.

3. Kirberg J, Berns A, von Boehmer H . Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 1997; 186: 1269–1275.

4. Nesic D, Vukmanovic S . MHC class I is required for peripheral accumulation of CD8+ thymic emigrants. J Immunol 1998; 160: 3705–3712.

5. Surh CD, Sprent J . Regulation of mature T cell homeostasis. Semin Immunol 2005; 17: 183–191.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?;Cancer Letters;2024-08

2. Retrovirale Vektoren – Effiziente Gentaxis für unterschiedliche Gentherapien;Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft;2023-12-30

3. Genome Editing in Engineered T Cells for Cancer Immunotherapy;Human Gene Therapy;2023-09-01

4. Modifying enzyme replacement therapy – A perspective;Journal of Cellular and Molecular Medicine;2022-12-25

5. Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms;Molecular Therapy;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3